Across
- 2. acronym for hepatitis attributed to hep c prior to discovery of the virus
- 4. name of medication often added to DAA regimen in patients with decompensated cirrhosis
- 6. patient who are co-infected with this virus are at increased risk of reactivation
- 7. brand name for combo DAA drug with all three classes of DAAs
- 9. name of drug that is a polymerase inhibitor
- 10. most common presentation of acute hepatitis c infection
- 12. number of genotypes of hep C
Down
- 1. brand name for combo DAA medication that should NOT be used for GT1 with NS5a resistance-associated substitutions
- 3. glecaprevir is a type of NS3 "blank" inhibitor
- 5. brand name for combo DAA medication safe to use in ESRD for all gentoypes
- 8. goal of treatment is a "blank" virologic response
- 11. patient population at risk of acquiring hep C
